Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease

Molecular Cell

Volumn 57, Issue 2, 2015, Pages 261-272

  Raththagala, Madushi ^a   Brewer, M Kathryn ^a   Parker, Matthew W ^a   Sherwood, Amanda R ^a   Wong, Brian K ^b   Hsu, Simon ^b   Bridges, Travis M ^a   Paasch, Bradley C ^a   Hellman, Lance M ^c   Husodo, Satrio ^a   Meekins, David A ^a   Taylor, Adam O ^a   Turner, Benjamin D ^a   Auger, Kyle D ^a   Dukhande, Vikas V ^a   Chakravarthy, Srinivas ^d   Sanz, Pascual ^e   Woods, Virgil L ^b   Li, Sheng ^b   Vander Kooi, Craig W ^a   Gentry, Matthew S ^a   more..

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NOTRE DAME   (United States)

^d ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^e CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAN; GLYCOGEN; LAFORIN; UNCLASSIFIED DRUG; EPM2A PROTEIN, HUMAN; MALTOHEXAOSE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; OLIGOSACCHARIDE; PHOSPHATE; PROTEIN BINDING;

ARTICLE; BIOCHEMISTRY; CRYSTAL STRUCTURE; GENE MUTATION; GLYCOGEN METABOLISM; HUMAN; MUTAGENESIS; MYOCLONUS EPILEPSY; NONHUMAN; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN QUATERNARY STRUCTURE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVE SITE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

MAMMALIA;

CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; GLYCOGEN; HUMANS; LAFORA DISEASE; MODELS, MOLECULAR; OLIGOSACCHARIDES; PHOSPHATES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR;

EID: 84921567531     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.11.020     Document Type: Article

References (53)

1. Berger P., Schaffitzel C., Berger I., Ban N., Suter U. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl. Acad. Sci. USA 2003, 100:12177-12182.
2. Berkovic S.F., So N.K., Andermann F. Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis. J.Clin. Neurophysiol. 1991, 8:261-274.
3. Blennow A., Engelsen S.B. Helix-breaking news: fighting crystalline starch energy deposits in the cell. Trends Plant Sci. 2010, 15:236-240.
4. Cavanagh J.B. Corpora-amylacea and the family of polyglucosan diseases. Brain Res. Brain Res. Rev. 1999, 29:265-295.
5. DePaoli-Roach A.A., Tagliabracci V.S., Segvich D.M., Meyer C.M., Irimia J.M., Roach P.J. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin. J.Biol. Chem. 2010, 285:25372-25381.
6. Dinuzzo M., Mangia S., Maraviglia B., Giove F. Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy?. Metab. Brain Dis. 2014, Published online March 19, 2014. 10.1007/s11011-014-9524-5.
7. Dukhande V.V., Rogers D.M., Romá-Mateo C., Donderis J., Marina A., Taylor A.O., Sanz P., Gentry M.S. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. PLoS ONE 2011, 6:e24040.
8. Duran J., Gruart A., García-Rocha M., Delgado-García J.M., Guinovart J.J. Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease. Hum. Mol. Genet. 2014, 23:3147-3156.
9. Fryer K.L., Brown A.M. Pluralistic roles for glycogen in the central and peripheral nervous systems. Metab. Brain Dis. 2014, Published online March 8, 2014. 10.1007/s11011-014-9516-5.
10. Gallant D.J., Bouchet B., Baldwin P.M. Microscopy of starch: evidence of a new level of granule organization. Carbohydr. Polym. 1997, 32:177-191.
11. Gentry M.S., Pace R.M. Conservation of the glucan phosphatase laforin is linked to rates of molecular evolution and the glucan metabolism of the organism. BMC Evol. Biol. 2009, 9:138.
12. Gentry M.S., Dowen R.H., Worby C.A., Mattoo S., Ecker J.R., Dixon J.E. The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease. J.Cell Biol. 2007, 178:477-488.
13. Gentry M.S., Dixon J.E., Worby C.A. Lafora disease: insights into neurodegeneration from plant metabolism. Trends Biochem. Sci. 2009, 34:628-639.
14. Hsu S., Kim Y., Li S., Durrant E.S., Pace R.M., Woods V.L., Gentry M.S. Structural insights into glucan phosphatase dynamics using amide hydrogen-deuterium exchange mass spectrometry. Biochemistry 2009, 48:9891-9902.
15. Koksal A.C., Cingolani G. Dimerization of Vaccinia virus VH1 is essential for dephosphorylation of STAT1 at tyrosine 701. J.Biol. Chem. 2011, 286:14373-14382.
16. Kötting O., Santelia D., Edner C., Eicke S., Marthaler T., Gentry M.S., Comparot-Moss S., Chen J., Smith A.M., Steup M., et al. STARCH-EXCESS4 is a laforin-like Phosphoglucan phosphatase required for starch degradation in Arabidopsis thaliana. Plant Cell 2009, 21:334-346.
17. Light P.E. Familial Wolff-Parkinson-White Syndrome: a disease of glycogen storage or ion channel dysfunction?. J.Cardiovasc. Electrophysiol. 2006, 17(1):S158-S161.
18. Liu Y., Wang Y., Wu C., Liu Y., Zheng P. Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling. J.Biol. Chem. 2006, 281:34768-34774.
19. Liu Y., Wang Y., Wu C., Liu Y., Zheng P. Deletions and missense mutations of EPM2A exacerbate unfolded protein response and apoptosis of neuronal cells induced by endoplasm reticulum stress. Hum. Mol. Genet. 2009, 18:2622-2631.
20. Lovatt D., Sonnewald U., Waagepetersen H.S., Schousboe A., He W., Lin J.H., Han X., Takano T., Wang S., Sim F.J., et al. The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J.Neurosci. 2007, 27:12255-12266.
21. Meekins D.A., Guo H.F., Husodo S., Paasch B.C., Bridges T.M., Santelia D., Kötting O., Vander Kooi C.W., Gentry M.S. Structure of the Arabidopsis glucan phosphatase like sex four2 reveals a unique mechanism for starch dephosphorylation. Plant Cell 2013, 25:2302-2314.
22. Meekins D.A., Raththagala M., Husodo S., White C.J., Guo H.F., Kötting O., Vander Kooi C.W., Gentry M.S. Phosphoglucan-bound structure of starch phosphatase Starch Excess4 reveals the mechanism for C6 specificity. Proc. Natl. Acad. Sci. USA 2014, 111:7272-7277.
23. Minassian B.A., Lee J.R., Herbrick J.A., Huizenga J., Soder S., Mungall A.J., Dunham I., Gardner R., Fong C.Y., Carpenter S., et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 1998, 20:171-174.
24. Minassian B.A., Andrade D.M., Ianzano L., Young E.J., Chan E., Ackerley C.A., Scherer S.W. Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase. Ann. Neurol. 2001, 49:271-275.
25. Moorhead G.B., De Wever V., Templeton G., Kerk D. Evolution of protein phosphatases in plants and animals. Biochem. J. 2009, 417:401-409.
26. Nitschke F., Wang P., Schmieder P., Girard J.M., Awrey D.E., Wang T., Israelian J., Zhao X., Turnbull J., Heydenreich M., et al. Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease. Cell Metab. 2013, 17:756-767.
27. Pantazatos D., Kim J.S., Klock H.E., Stevens R.C., Wilson I.A., Lesley S.A., Woods V.L. Rapid refinement of crystallographic protein construct definition employing enhanced hydrogen/deuterium exchange MS. Proc. Natl. Acad. Sci. USA 2004, 101:751-756.
28. Pfeiffer-Guglielmi B., Fleckenstein B., Jung G., Hamprecht B. Immunocytochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies. J.Neurochem. 2003, 85:73-81.
29. Phan J., Tropea J.E., Waugh D.S. Structure-assisted discovery of Variola major H1 phosphatase inhibitors. Acta Crystallogr. D Biol. Crystallogr. 2007, 63:698-704.
30. Roach P.J. Glycogen and its metabolism. Curr. Mol. Med. 2002, 2:101-120.
31. Roach P.J., Depaoli-Roach A.A., Hurley T.D., Tagliabracci V.S. Glycogen and its metabolism: some new developments and old themes. Biochem. J. 2012, 441:763-787.
32. Ros S., Schulze A. Linking glycogen and senescence in cancer cells. Cell Metab. 2012, 16:687-688.
33. Saez I., Duran J., Sinadinos C., Beltran A., Yanes O., Tevy M.F., Martínez-Pons C., Milán M., Guinovart J.J. Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia. J.Cereb. Blood Flow Metab. 2014, 34:945-955.
34. Sánchez-Martín P., Raththagala M., Bridges T.M., Husodo S., Gentry M.S., Sanz P., Romá-Mateo C. Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329. PLoS ONE 2013, 8:e69523.
35. Santelia D., Kötting O., Seung D., Schubert M., Thalmann M., Bischof S., Meekins D.A., Lutz A., Patron N., Gentry M.S., et al. The phosphoglucan phosphatase like sex Four2 dephosphorylates starch at the C3-position in Arabidopsis. Plant Cell 2011, 23:4096-4111.
36. Serratosa J.M., Gómez-Garre P., Gallardo M.E., Anta B., de Bernabé D.B., Lindhout D., Augustijn P.B., Tassinari C.A., Malafosse R.M., Topcu M., et al. A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum. Mol. Genet. 1999, 8:345-352.
37. Sherwood A.R., Paasch B.C., Worby C.A., Gentry M.S. A malachite green-based assay to assess glucan phosphatase activity. Anal. Biochem. 2013, 435:54-56.
38. Silver D.M., Kötting O., Moorhead G.B. Phosphoglucan phosphatase function sheds light on starch degradation. Trends Plant Sci. 2014, 19:471-478.
39. Sinadinos C., Valles-Ortega J., Boulan L., Solsona E., Tevy M.F., Marquez M., Duran J., Lopez-Iglesias C., Calbó J., Blasco E., et al. Neuronal glycogen synthesis contributes to physiological aging. Aging Cell 2014, 13:935-945.
40. Streb S., Zeeman S.C. Starch metabolism in Arabidopsis. Arabidopsis Book 2012, 10:e0160.
41. Swanson R.A. Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can. J. Physiol. Pharmacol. 1992, 70:S138-S144.
42. Tagliabracci V.S., Turnbull J., Wang W., Girard J.M., Zhao X., Skurat A.V., Delgado-Escueta A.V., Minassian B.A., Depaoli-Roach A.A., Roach P.J. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen invivo. Proc. Natl. Acad. Sci. USA 2007, 104:19262-19266.
43. Tagliabracci V.S., Girard J.M., Segvich D., Meyer C., Turnbull J., Zhao X., Minassian B.A., Depaoli-Roach A.A., Roach P.J. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J.Biol. Chem. 2008, 283:33816-33825.
44. Tagliabracci V.S., Heiss C., Karthik C., Contreras C.J., Glushka J., Ishihara M., Azadi P., Hurley T.D., DePaoli-Roach A.A., Roach P.J. Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab. 2011, 13:274-282.
45. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006, 7:833-846.
46. Tonks N.K. Protein tyrosine phosphatases-from housekeeping enzymes to master regulators of signal transduction. FEBS J. 2013, 280:346-378.
47. Turnbull J., DePaoli-Roach A.A., Zhao X., Cortez M.A., Pencea N., Tiberia E., Piliguian M., Roach P.J., Wang P., Ackerley C.A., Minassian B.A. PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet. 2011, 7:e1002037.
48. Valles-Ortega J., Duran J., Garcia-Rocha M., Bosch C., Saez I., Pujadas L., Serafin A., Cañas X., Soriano E., Delgado-García J.M., et al. Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Mol. Med. 2011, 3:667-681.
49. Vander Kooi C.W., Taylor A.O., Pace R.M., Meekins D.A., Guo H.F., Kim Y., Gentry M.S. Structural basis for the glucan phosphatase activity of Starch Excess4. Proc. Natl. Acad. Sci. USA 2010, 107:15379-15384.
50. Vilchez D., Ros S., Cifuentes D., Pujadas L., Vallès J., García-Fojeda B., Criado-García O., Fernández-Sánchez E., Medraño-Fernández I., Domínguez J., et al. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat. Neurosci. 2007, 10:1407-1413.
51. Wang J., Stuckey J.A., Wishart M.J., Dixon J.E. A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J.Biol. Chem. 2002, 277:2377-2380.
52. Worby C.A., Gentry M.S., Dixon J.E. Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J.Biol. Chem. 2006, 281:30412-30418.
53. Yokoi S., Austin J., Witmer F., Sakai M. Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch. Neurol. 1968, 19:15-33.